Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mepro Pharmaceuticals is a leading Indian pharmaceutical manufacturer with over three decades of experience, specializing in the development and large-scale production of generic medicines across multiple dosage forms including tablets, capsules, creams/ointments, and sterile injectables. The company has a strong global presence in more than 40 countries and holds regulatory approvals from major agencies such as UK MHRA and PIC/S nations. It is known for its robust R&D capabilities, having registered over 1000 products globally, including complex generics and orphan drugs. Its manufacturing facilities are GMP-compliant and serve both regulated markets like Europe/Australia/Canada/UK as well as emerging markets in Asia, Africa, Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mepro Pharmaceuticals.